NCT02199717

Brief Summary

This pilot project was developed to investigate subjective and objective data related to the patterns of physical activity participation among hemophilia patients (FVIII or FIX) between the ages of 5 and 18 years. Physical activity participation among different levels of disease severity will be compared using accelerometers to calculate the amount of time spent in moderate to vigorous physical activity (MVPA) and the number of bouts of MVPA; additionally, data will be collected from two validated questionnaires (PedHAL and 3 day physical activity recall). Current literature that relates level of physical activity to disease severity in the pediatric hemophilia population is limited. The information gained about the type and quantity of physical activity participation in children with varying levels of hemophilia will assist in the development of education and interventions to promote good physical activity and potentially examine the role of tailored prophylaxis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

July 23, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 24, 2014

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
3 months until next milestone

Results Posted

Study results publicly available

December 14, 2016

Completed
Last Updated

December 14, 2016

Status Verified

December 1, 2016

Enrollment Period

10 months

First QC Date

July 23, 2014

Results QC Date

October 12, 2016

Last Update Submit

December 8, 2016

Conditions

Keywords

Physical ActivityAccelerometerExerciseObesityBMI

Outcome Measures

Primary Outcomes (2)

  • MVPA

    To determine if the amount of time spent performing moderate to vigorous physical activity (MVPA) engaged in on a weekly basis differs by the level of disease severity in the pediatric hemophilia population.

    7 days

  • Sedentary Time

    To determine if the amount of time spent in sedentary time on a weekly basis differs by the level of disease severity in the pediatric hemophilia population.

    7 days

Study Arms (1)

Boys with Hemophilia

Accelerometer use for 1 week.

Device: Accelerometer

Interventions

Also known as: ActiLife, Kinesoft
Boys with Hemophilia

Eligibility Criteria

Age5 Years - 17 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients will be 5 to 18 years of age with a diagnosis of hemophilia with no history of inhibitors or pre-existing co-morbidity (e.g. cerebral palsy, chronic respiratory conditions, congenital heart defects) that can affect activity participation.

You may qualify if:

  • years of age, has a diagnosis of Hemophilia A or B.

You may not qualify if:

  • Muscle or joint bleed within 4 weeks of study.
  • Pre-existing co-morbidities that would affect physical activity participation.
  • Unable to cooperate with study protocol.
  • Unable to speak, read, or understand English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SickKids

Toronto, Ontario, M5G1X8, Canada

Location

MeSH Terms

Conditions

Hemophilia AHemophilia BMotor ActivityObesity

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, X-LinkedBehaviorOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Vanessa Bouskill NP
Organization
Hospital for Sick Children

Study Officials

  • Vanessa Bouskill, NP, MN

    The Hospital for Sick Children

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nurse Practitioner

Study Record Dates

First Submitted

July 23, 2014

First Posted

July 24, 2014

Study Start

September 1, 2013

Primary Completion

July 1, 2014

Study Completion

September 1, 2016

Last Updated

December 14, 2016

Results First Posted

December 14, 2016

Record last verified: 2016-12

Locations